Country: যুক্তরাজ্য
ভাষা: ইংরেজি
সূত্র: VMD (Veterinary Medicines Directorate)
Dinoprost
Zoetis UK Limited
QG02AD01
Dinoprost
Solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Cattle
Prostaglandin
Authorized
2015-12-02
Revised: April 2021 AN: 01269/2020 Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Lutalyse 12.5 mg/ml solution for injection for cattle 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Dinoprost 12.5 mg (as Dinoprost tromethamine) EXCIPIENT: Benzyl alcohol 16.5 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. Clear colourless to pale yellow solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Lutalyse is indicated for its luteolytic and/or oxytocic effects in cattle. The indications for use are: 1. To more effectively control the time of oestrus in cycling cows. 2. To treat cows which have a functional corpus luteum, but do not express behavioural oestrus (sub-oestrus or silent heat). 3. To induce abortion. 4. To induce parturition. 5. For treatment of chronic metritis and pyometra. 6. For controlled breeding in normally cycling dairy cows: oestrus synchronisation ovulation synchronisation in combination with GnRH or GnRH analogues as part of fixed time artificial insemination protocols. 4.3 CONTRAINDICATIONS Do not use in animals suffering from either acute or sub-acute disorders of the vascular system, gastro-intestinal tract or respiratory system. Revised: April 2021 AN: 01269/2020 Page 2 of 8 Do not use when abortion or parturition is not intended. Do not administer by the intravenous route. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES For intramuscular use in cattle only. Do not administer more than 2 ml per single injection Lutalyse is ineffective when administered prior to day five after ovulation. Administration of Lutalyse to cattle within four days after oestrus is unlikely to result in luteolysis of the corpus luteum. Administration within 48 hours before onset of the next oestrus may not influence the timing of the oestrus after treatment. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals সম্পূর্ণ নথি পড়ুন